tislelizumab
beigene,novartis
tislelizumab plus chemotherapy elicits strong survival benefit in esophageal cancer #wcgic2022 #esmogi22 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.